Welcome to our dedicated page for Fonar SEC filings (Ticker: FONR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fonar Corporation (FONR) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, alongside AI-generated summaries. Fonar is a Nasdaq-listed medical device and diagnostic imaging management company that designs, manufactures, sells and services MRI scanners and manages MRI centers through its subsidiary Health Management Company of America (HMCA). Its filings provide structured insight into both the MRI equipment segment and the management of diagnostic imaging centers.
Through annual reports on Form 10-K and quarterly reports on Form 10-Q, Fonar details its two reportable segments: manufacturing and servicing of medical equipment, and the management of diagnostic imaging centers. These filings describe revenues from product sales, upgrades, service and repair fees, as well as patient fee revenue and management and other fees generated by HMCA-managed MRI centers in New York and Florida. They also present information on total revenues, income from operations, net income, cash and cash equivalents, assets, liabilities, working capital and scan volumes.
Current reports on Form 8-K highlight significant corporate events. For example, an 8-K dated November 12, 2025 notes that Fonar issued a press release reporting results of operations and financial condition for the first quarter of fiscal 2026. Other 8-K filings in 2025 describe the receipt of non-binding and supplemental proposals from an acquisition group led by the company’s chief executive officer to acquire all outstanding capital stock not already owned by the group, and the company’s related press releases. Additional 8-K reports cover board and governance changes, such as the retirement of a director and secretary and the appointment of an independent director.
In December 2025, Fonar announced in a press release that it had entered into a definitive merger agreement with an acquisition group led by its chief executive officer. While the detailed terms and risk factors are set out in SEC materials such as the planned proxy statement on Schedule 14A and a Schedule 13E-3 transaction statement, this filings page helps users locate those documents once filed. The company has indicated that these materials will contain important information about the proposed going-private transaction, including the terms and conditions of the merger and the process followed by the special committee of independent directors.
On Stock Titan, AI-powered tools assist users by summarizing lengthy Fonar filings, such as 10-K and 10-Q reports, into key points about segment performance, liquidity, capital structure and HMCA operations. For investors interested in governance and insider activity, the platform also surfaces relevant forms, including 8-Ks that report material events. Real-time updates from EDGAR ensure that new FONR filings, including proxy materials related to the proposed going-private transaction, appear promptly, while AI-generated explanations help clarify complex accounting and legal disclosures.
FONAR Corp received a Schedule 13G reporting a significant ownership position by the Hilary L. Shane Revocable Trust and Hilary L. Shane. The filing states beneficial ownership of 413,206 shares of FONAR common stock, representing 6.66% of the outstanding class. All of these shares are reported with shared voting and shared dispositive power, with no sole voting or dispositive power.
The report is filed on a passive basis, with the certifying statement that the securities were not acquired and are not held for the purpose of changing or influencing control of FONAR Corp, and are not part of any control-related transaction.
FONAR Corporation filed an 8‑K to announce that it reported results for the first quarter of Fiscal 2026, which ended September 30, 2025. The company furnished a press release dated November 10, 2025 under Exhibit 99.1.
FONAR’s common stock trades on the Nasdaq Stock Exchange under the symbol FONR.
FONAR Corporation reported Q1 FY2026 results for the three months ended September 30, 2025. Total revenue was $26.043 million, up 4.3% year over year, while operating income fell to $3.194 million from $4.606 million as costs rose faster than sales. Net income attributable to FONAR was $2.264 million, and net income available to common stockholders was $2.120 million, with basic and diluted EPS of $0.34.
Growth was led by management and other fees and higher product and service activity. The company performed 55,106 scans, up from 53,054. Expenses increased 12.2% to $22.849 million, reflecting a prior-year $600,000 over‑accrual benefit, costs tied to the proposed going‑private transaction, IT and cybersecurity spending, and a $100,000 credit loss reserve increase primarily related to American Transit Insurance Company.
Cash and equivalents were $54.276 million (down from $56.334 million at June 30, 2025). Operating cash flow was $1.689 million; investing used $2.367 million and financing used $1.380 million. A CEO/COO‑led group submitted a non‑binding proposal on July 7, 2025 to acquire all outstanding equity; a Special Committee is negotiating, and no definitive agreements have been executed. The stock repurchase plan remains suspended, with $2.928 million authorization remaining.
FONAR Corporation (Form 10-K) reported consolidated financial and operational details for fiscal 2025, highlighting its continued majority ownership of Health Diagnostics Management (HDM) and material credit reserving. The company sold a non-controlling interest for $132,000, leaving a direct HDM ownership of 70.63% and investors with 29.37%. Management tested internal controls over patient fee revenue, CECL estimates and IT general controls for its billing systems.
The filing discloses an allowance for credit losses of $4,366,000, recorded valuation allowances against state net operating losses, and detailed share activity including repurchases: the company repurchased 114,588 shares at a cost of $1,806,646 and cancelled 124,829 shares valued at $1,963,385. The company derives a large portion of revenues from no-fault and personal injury protection (about 67% of net revenues).
Money Concepts Capital Corp reported owning 462,760 shares of FONAR Corp common stock, representing 7.5% of the class. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
The filer reports sole dispositive power over 462,760 shares and no voting power (sole or shared). The Schedule 13G/A identifies the filers principal office in Palm Beach Gardens, Florida, and lists the issuers principal executive office in Melville, New York.
Renaissance Technologies reports a 5.09% stake in Fonar Corporation, representing 315,516 shares held with sole voting and dispositive power. That level of ownership makes Renaissance a material minority investor but the filing states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control.
Two related entities—Renaissance Technologies LLC (an investment adviser) and Renaissance Technologies Holdings Corporation (a holding company)—report identical ownership and note that certain funds they manage have the right to receive dividends or sale proceeds from these shares.
Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 544,036 shares of Fonar Corp ordinary stock, representing 8.8% of the class. The filer indicates sole voting power and sole dispositive power over all reported shares. The statement is filed as a Schedule 13G amendment and the filer certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing lists the reporting person as an investment adviser (Type IA) and notes no shared power or group affiliation.
FAQ
What is the current stock price of Fonar (FONR)?
What is the market cap of Fonar (FONR)?
